Traduction de «susceptibilities and clinical outcomes » (Néerlandais → Français) :

40. White AC Jr, Atmar RL, Wilson J et al: Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities and clinical outcomes.
40. White AC Jr, Atmar RL, Wilson J et al : Effects of requiring prior authorization for selected antimicrobials : expenditures, susceptibilities and clinical outcomes.

Powerpoint slides sprekers - Toespraak - Staatssecretaris Servais Verherstraeten - Toespraak - Minister Laurette Onkelinx - Inleiding - Prof. Jean Nève - Presentatie " Environment, health, science and progress" - Prof. Andreas Gies - Presentatie " Een advies van de HGR inzake Volksgezondheid en Duurzame ontwikkeling" - Prof. Luc Hens - Presentatie " Radon binnenshuis en duurzame ontwikkeling" - Prof. François Jamar - Presentatie " Voeding en duurzame ontwikkeling" - Prof. Stefaan De Henauw - Presentatie " Vergrijzing en duurzame ontwikkeling" - Prof. Jacques De Mol - Présentation " Molecular detection of noroviruses in ready-to-eat foods and fruit products" - Ambroos Stals (HGR Priis) - Présentation " Immune Monitoring in Type 1 Diabetic Recipients of Defined Beta Cell Graft: Contribution to Assess Clinical Outcome" - Robert Hilbrands (HGR Prijs)
Powerpoint slides intervenants - Allocution - Secrétaire d'état Servais Verherstraeten - Allocution - Ministre Laurette Onkelinx - Introduction - Prof. Jean Nève - Présentation " Environment, health, science and progress" - Prof. Andreas Gies - Présentation " Un avis du CSS en matière de Santé Publique et Développement durable" - Prof. Luc Hens - Présentation " Radon à domicile et développement durable" - Prof. François Jamar - Présentation " Alimentation et développement durable" - Prof. Stefaan De Henauw - Présentation " Vieillissement de la population et développement durable" - Prof. Jacques De Mol - Présentation " Molecular detection of noroviruses in ready-to-eat foods and fruit products" - Ambroos Stals (Prix CSS) - Présentation " Immune Monitoring in Type 1 Diabetic Recipients of Defined Beta Cell Graft: Contribution to Assess Clinical Outcome" - Robert Hilbrands (Prix CSS)

De tweede prijs werd uitgereikt aan de heer Robert HILBRANDS voor zijn thesisonderzoek: " Immune Monitoring in Type 1 Diabetic Recipients of Defined Beta Cell Grafts: Contribution to Assess Clinical Outcome" .
Le second prix a été attribué à Mr Robert HILBRANDS pour son travail intitulé : « Immune Monitoring in Type 1 Diabetic Recipients of Defined Beta Cell Grafts: Contribution to Assess Clinical Outcome ».

A Retrospective Analysis of Surgical Treatment in Patients With Symptomatic Hallux Rigidus: Long-Term Follow-Up The objective of this retrospective study was to analyze the long-term clinical outcomes and patient satisfaction of operative care in patients with symptomatic halluxrigidus.
A Retrospective Analysis of Surgical Treatment in Patients With Symptomatic Hallux Rigidus: Long-Term Follow-Up The objective of this retrospective study was to analyze the long-term clinical outcomes and patient satisfaction of operative care in patients with symptomatic hallux rigidus.

23. Sanders CC, laconis JP, Bodey GP, Samonis G: Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriacae: rote of PSE-ESBL-1 betalactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
23. Sanders CC, laconis JP, Bodey GP, Samonis G : Résistance to ticarcillin-potassium clavulanate among clinical isolates of thé family Enterobacteriacae : rote of PSE-ESBL-1 betalactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

7+2 : meta-meta-analysis of the probability of superior outcome in comparisons involving therapy, placebo, and control». , Journal of Consulting and Clinical Psychology, 1996, 64 : 973-982.
EDELSON M., « Hypothesis and Evidence in Psychoanalysis », Chicago, University of Chicago Press, 1984.

a. “The Clinical Management and Outcome of Nail Salon–Acquired Mycobacterium fortuitum Skin Infection ” Kevin L. Winthrop et al. CID 2004:38 (1 January).
a) “The Clinical Management and Outcome of Nail Salon–Acquired Mycobacterium fortuitum Skin Infection ” Kevin L. Winthrop et al. CID 2004:38 (1 January).

The clinical significance of heterogeneous glycopeptide intermediate S. aureus (hGISA; borderline susceptible strains) is unclear, although recent data suggest that the response to the glycopeptide therapy administered to patients infected by such variants can be poor.
La signification clinique de S. aureus intermédiaire aux glycopeptides hétérogènes (hGISA; les souches sensibles limites) est peu claire bien que les données récentes suggèrent que la réponse à la thérapie aux glycopeptides des patients infectés par de telles variantes peut être insuffisante.

3.3.2 Determination of susceptibility to vancomycin Homogeneous glycopeptide intermediate resistant strains (vancomycin MIC of 8 mg/L or teicoplanin 16 mg/L) have been related to clinical failure of glycopeptide treatment.
3.3.2 Détermination de la sensibilité à la vancomycine Un lien a été établi entre les souches résistantes intermédiaires glycopeptides homogènes (vancomycin MIC de 8 mg/L ou teicoplanine 16 mg/L) et l'échec clinique du traitement au glycopeptide.

Testing gentamicin, rifampin, fusidic acid and linezolid susceptibility is recommended for cases of clinical infection, not for colonisation.
Le test de la sensibilité à la gentamicine, la rifampine, l’acide fusidique et au linézolide est recommandé pour les cas d'infection clinique, non pour la colonisation.